News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
512,797 Results
Type
Article (35218)
Company Profile (76)
Press Release (477503)
Section
Business (145970)
Career Advice (2365)
Deals (26574)
Drug Delivery (86)
Drug Development (70197)
Employer Resources (135)
FDA (12987)
Job Trends (11566)
News (260303)
Policy (25682)
Tag
Academia (2392)
Alliances (36271)
Alzheimer's disease (1273)
Approvals (12954)
Artificial intelligence (147)
Bankruptcy (296)
Best Places to Work (9490)
Breast cancer (187)
Cancer (1369)
Cardiovascular disease (123)
Career advice (1984)
CAR-T (95)
Cell therapy (281)
Clinical research (56533)
Collaboration (461)
Compensation (134)
COVID-19 (2325)
C-suite (142)
Data (1392)
Diabetes (177)
Diagnostics (5356)
Earnings (52080)
Employer resources (124)
Events (69563)
Executive appointments (469)
FDA (13671)
Funding (440)
Gene therapy (204)
GLP-1 (586)
Government (3919)
Healthcare (15308)
Infectious disease (2415)
Inflammatory bowel disease (102)
Interviews (513)
IPO (11943)
Job creations (2419)
Job search strategy (1627)
Layoffs (368)
Legal (5338)
Lung cancer (221)
Manufacturing (175)
Medical device (10082)
Medtech (10086)
Mergers & acquisitions (14854)
Metabolic disorders (464)
Neuroscience (1635)
NextGen: Class of 2025 (5212)
Non-profit (3787)
Northern California (1502)
Obesity (252)
Opinion (187)
Parkinson's disease (99)
Patents (123)
People (48628)
Phase I (17381)
Phase II (24910)
Phase III (19012)
Pipeline (581)
Postmarket research (2194)
Preclinical (6962)
Radiopharmaceuticals (199)
Rare diseases (254)
Real estate (3791)
Regulatory (17848)
Research institute (1983)
Resumes & cover letters (343)
Southern California (1327)
Startups (2524)
United States (13047)
Vaccines (499)
Weight loss (183)
Date
Today (110)
Last 7 days (332)
Last 30 days (1588)
Last 365 days (28991)
2025 (1401)
2024 (29342)
2023 (33026)
2022 (43268)
2021 (46246)
2020 (44753)
2019 (38060)
2018 (28839)
2017 (25867)
2016 (24457)
2015 (28631)
2014 (21271)
2013 (17137)
2012 (18309)
2011 (19387)
2010 (17118)
Location
Africa (678)
Arizona (118)
Asia (31797)
Australia (6752)
California (3368)
Canada (1353)
China (309)
Colorado (151)
Connecticut (149)
Europe (70453)
Florida (518)
Georgia (115)
Illinois (333)
Indiana (199)
Maryland (590)
Massachusetts (2378)
Michigan (160)
Minnesota (226)
New Jersey (975)
New York (962)
North Carolina (604)
Northern California (1502)
Ohio (119)
Pennsylvania (761)
South America (936)
Southern California (1327)
Texas (497)
Utah (112)
Washington State (352)
512,797 Results for "oncoinvent as".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncoinvent Announces Agreement with ARTBIO to Collaborate on Radiopharma Laboratory Facilities
December 4, 2024
·
2 min read
Press Releases
Oncoinvent to Present at JonesTrading Virtual Radiopharma Day
October 28, 2024
·
1 min read
FDA
Oncoinvent Receives FDA Fast Track Designation for Radspherin® as Treatment for Peritoneal Carcinomatosis from Ovarian Cancer
Oncoinvent Receives FDA Fast Track Designation for Radspherin ® as Treatment for Peritoneal Carcinomatosis from Ovarian Cancer.
June 24, 2024
·
3 min read
Press Releases
Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses
November 11, 2024
·
5 min read
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
Oncoinvent AS today announced that members of management will participate in a virtual fireside chat at the Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit on Monday, May 20, 2024 at 9:00 a.m. ET.
May 15, 2024
·
2 min read
Oncoinvent to Present at Evercore ISI 2024 Emerging Biotech Conference
Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced that members of management will present at the Evercore ISI 2024 Emerging Biotech Conference on Wednesday, February 28, 2024 at 11:20 a.m. ET.
February 21, 2024
·
2 min read
Press Releases
Oncoinvent Announces Publication of 18-Month Safety and Efficacy Data from the Phase 1/2a Study of Radspherin® in Colorectal Cancer
November 1, 2024
·
3 min read
Press Releases
Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients
October 10, 2024
·
3 min read
Business
Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific and Clinical Advisory Board
Oncoinvent AS announced the appointment of newly elected members of its Board of Directors and the formation of a Scientific and Clinical Advisory Board under the leadership of founding scientists Roy Larsen and Øyvind Bruland, previous board members and leading experts in oncology and pharmaceutical development.
April 2, 2024
·
6 min read
Business
Oncoinvent appoints Anders Månsson as CEO
Oncoinvent AS today announced the appointment of Anders Månsson as Chief Executive Officer (CEO), effective September 1st , 2023.
July 5, 2023
·
3 min read
1 of 51,280
Next
